Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett, Daniel A. Haber, Anahita Dastur et al.|Nature|2012Cited by 2.6k
Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinibFuminori Takahashi, Shyamala Maheswaran, Naokazu Chiba et al.|Oncogene|2011Cited by 66